 Proactive Investors USA & Canada | Islet Sciences chooses NeoStem unit for product manufacturing Pharmaceutical Business Review As per the deal, PCT will perform microencapsulation for parsing beta pancreatic islets for xenotransplantation using piglet pancreata. Islet Sciences CEO John Steel said NeoStem has agreed to deal whereby PCT will subsidize manufacturing margin ... Islet Sciences, Inc. Selects NeoStem's Manufacturing Subsidiary Progenitor ... NeoStem's PCT unit selected for product manufacturing for diabetes therapy |
